Results: High frequencies of CD34+TIM-3+ cells at diagnosis were related to high relapse rates in AML patients with t(8;21) (p = 0.025) but not in non-CBF-AML patients (p = 0.16). This evidence concerns the gene HAVCR2 and acute myeloid leukemia.